The Asfora Bullet Cage is designed for use in posterior lumbar interbody fusion surgeries to treat degenerative disc disease, according to the release. Dr. Asfora noted in clinical experience to date that the implant has a 98 percent rate of interbody fusion of one or two levels using locally harvested bone without unexpected complications or the use of pedicle screws or bone morphogenic protein.
The Asfora Bullet Cage will be manufactured and sold by Medical Designs, LLC, a company owned by Dr. Asfora and based in Sioux Falls.
Read the Sanford Health release about the FDA 510(k) market approval of the Asfora Bullet Cage.
